title: [From HAART to "smart": maximizing the advantages of lopinavir/ritonavir].
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects / Q000379:methods*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D008134:Long-Term Care; D061466:Lopinavir; D011744:Pyrimidinones / Q000008:administration & dosage* / Q000009:adverse effects; D019438:Ritonavir / Q000008:administration & dosage* / Q000009:adverse effects; D019562:Viral Load
chemical_list: D003692:Delayed-Action Preparations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir
vernacular_title: Von HAART zu "smart": Die Vorteile von Lopinavir/Ritonavir maximal nutzen.